MANGALAM — Mangalam Drugs and Organics Cashflow Statement
0.000.00%
- IN₹1.21bn
- IN₹1.87bn
- IN₹3.69bn
- 87
- 86
- 29
- 79
Annual cashflow statement for Mangalam Drugs and Organics, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 62.5 | 395 | 277 | 22.1 | -111 |
Depreciation | |||||
Non-Cash Items | 105 | 80.6 | 121 | 129 | 132 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 55.9 | -292 | -244 | 134 | -45.9 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 305 | 275 | 257 | 395 | 122 |
Capital Expenditures | -69.3 | -314 | -277 | -279 | -179 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0.594 | 1.51 | 3.43 | 57.4 | 0.112 |
Sale of Fixed Assets | |||||
Change in Net Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -68.7 | -313 | -273 | -222 | -179 |
Financing Cash Flow Items | -104 | -93.3 | -112 | -128 | -139 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -235 | 27 | 29.8 | -166 | 57 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 1.96 | -10.4 | 13.6 | 7.34 | -0.373 |